Chemoinformaics analysis of aesculin and cichoriin
| Molecular Weight | 340.284 | nRot | 3 |
| Heavy Atom Molecular Weight | 324.156 | nRig | 18 |
| Exact Molecular Weight | 340.079 | nRing | 3 |
| Solubility: LogS | -1.864 | nHRing | 2 |
| Solubility: LogP | -0.622 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 11 |
| nHA | 9 | APOL | 42.9367 |
| nHD | 5 | BPOL | 22.1273 |
| QED | 0.429 |
| Synth | 3.732 |
| Natural Product Likeliness | 2.146 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.644 |
| HIA | 0.471 |
| CACO-2 | -6.013 |
| MDCK | 0.0000301 |
| BBB | 0.203 |
| PPB | 0.648617 |
| VDSS | 0.616 |
| FU | 0.322864 |
| CYP1A2-inh | 0.14 |
| CYP1A2-sub | 0.093 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.209 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.23 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.031 |
| CL | 3.843 |
| T12 | 0.789 |
| hERG | 0.22 |
| Ames | 0.288 |
| ROA | 0.036 |
| SkinSen | 0.395 |
| Carcinogencity | 0.496 |
| EI | 0.147 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.589187 |